GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (MIL:PHN) » Definitions » Interest Expense

PharmaNutra SpA (MIL:PHN) Interest Expense : €-1.6 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PharmaNutra SpA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PharmaNutra SpA's interest expense for the three months ended in Sep. 2024 was € -0.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PharmaNutra SpA's Operating Income for the three months ended in Sep. 2024 was € 6.7 Mil. PharmaNutra SpA's Interest Expense for the three months ended in Sep. 2024 was € -0.4 Mil. PharmaNutra SpA's Interest Coverage for the quarter that ended in Sep. 2024 was 17.55. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


PharmaNutra SpA Interest Expense Historical Data

The historical data trend for PharmaNutra SpA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaNutra SpA Interest Expense Chart

PharmaNutra SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only -0.04 -0.03 -0.02 -0.06 -1.01

PharmaNutra SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.38 -0.32 -0.49 -0.38

PharmaNutra SpA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaNutra SpA  (MIL:PHN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmaNutra SpA's Interest Expense for the three months ended in Sep. 2024 was €-0.4 Mil. Its Operating Income for the three months ended in Sep. 2024 was €6.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €20.3 Mil.

PharmaNutra SpA's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*6.651/-0.379
=17.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


PharmaNutra SpA Business Description

Traded in Other Exchanges
Address
Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia, and others.

PharmaNutra SpA Headlines

No Headlines